Interview with Maria Jesús Arranz

Leader of use case 3, a doctor in biology. Head of the Research Laboratory Unit at the Fundació Mútua Terrassa since 2011. Dr. Maria Jesús's work on the pharmacogenetics of antipsychotics is well known, having published leading papers on the use of pharmacogenetics for the prediction of response to antipsychotic and antidepressant treatments. Her specialisation and expertise is an important part of the BETTER Project!

Watch her interview to hear more about Maria Jesús’s role, her motivation and expectations for the BETTER project.



Please accept our cookies. Data is collected with respect for privacy. All requests to third party servers are anonymised so no user-identifying information is shared.

Funded by the EU

UKRI
The project has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement No 101136262. The communication reflects only the author's view and the Commission is not responsible for any use that may be made of the information it contains.

Privacy Policy

Follow us:
linkedin
Twitter/X